ArticleThe Lancet regional health. Europe2023

Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.

Mark Joy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.